Supplemental Consolidating Data - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 27, 2022
Cash flows from operating activities:
Net income	$ 301,829	$ 222,502
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization	34,352	39,258
Amortization of deferred loan origination costs	21,858	22,995
Amortization of financing origination fees	3,011	3,701
Provision for long-term employee benefits	(16,939)	(5,050)
Employee benefit plan contributions and payments	(1,739)	(2,143)
Stock compensation expense	23,628	8,903
Net change in wholesale finance receivables related to sales	(487,314)	(205,727)
Provision for credit losses	52,364	28,822
Deferred income taxes	5,648	6,307
Other, net	(21,671)	(5,408)
Changes in current assets and liabilities:
Accounts receivable, net	(77,993)	(74,993)
Finance receivables – accrued interest and other	2,252	3,115
Inventories, net	123,047	(2,630)
Accounts payable and accrued liabilities	43,787	106,969
Other current assets	40,557	(7,300)
Total adjustments	(255,152)	(83,181)
Net cash provided by operating activities	46,677	139,321
Cash flows from investing activities:
Capital expenditures	(45,114)	(27,999)
Origination of finance receivables	(917,145)	(1,058,461)
Collections on finance receivables	890,852	965,190
Other investing activities	821	135
Net cash used by investing activities	(70,586)	(121,135)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	693,276	495,785
Repayments of medium-term notes	(350,000)	(550,000)
Proceeds from securitization debt	547,706	0
Repayments of securitization debt	(310,640)	(271,499)
Borrowings of asset-backed commercial paper	0	62,455
Repayments of asset-backed commercial paper	(62,634)	(56,634)
Net (decrease) increase in unsecured commercial paper	(270,119)	64,521
Net increase in deposits	51,822	57,660
Dividends paid	(24,123)	(24,056)
Repurchase of common stock	(96,767)	(261,737)
Other financing activities	69	0
Net cash provided (used) by financing activities	178,590	(483,505)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3,820	(1,743)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	1,579,177	2,025,219
Net (decrease) increase in cash, cash equivalents and restricted cash	158,501	(467,062)
Cash, cash equivalents and restricted cash, end of period	1,737,678	1,558,157
Non-Financial Services Entities
Cash flows from financing activities:
Proceeds from securitization debt	0
Financial Services Entities
Cash flows from financing activities:
Proceeds from securitization debt	547,706
Reportable Legal Entities | Non-Financial Services Entities
Cash flows from operating activities:
Net income	256,385	158,961
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization	32,120	37,106
Amortization of deferred loan origination costs	0	0
Amortization of financing origination fees	177	174
Provision for long-term employee benefits	(16,939)	(5,050)
Employee benefit plan contributions and payments	(1,739)	(2,143)
Stock compensation expense	22,494	8,233
Net change in wholesale finance receivables related to sales	0	0
Provision for credit losses	0	0
Deferred income taxes	4,261	6,176
Other, net	(18,087)	(5,322)
Changes in current assets and liabilities:
Accounts receivable, net	(426,221)	(319,329)
Finance receivables – accrued interest and other	0	0
Inventories, net	123,047	(2,630)
Accounts payable and accrued liabilities	14,610	86,546
Other current assets	25,342	(47,418)
Total adjustments	(240,935)	(243,657)
Net cash provided by operating activities	15,450	(84,696)
Cash flows from investing activities:
Capital expenditures	(44,894)	(27,149)
Origination of finance receivables	0	0
Collections on finance receivables	0	0
Other investing activities	821	135
Net cash used by investing activities	(44,073)	(27,014)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	0	0
Repayments of medium-term notes	0	0
Repayments of securitization debt	0	0
Borrowings of asset-backed commercial paper		0
Repayments of asset-backed commercial paper	0	0
Net (decrease) increase in unsecured commercial paper	0	0
Net increase in deposits	0	0
Dividends paid	(24,123)	(24,056)
Repurchase of common stock	(96,767)	(261,737)
Other financing activities	69
Net cash provided (used) by financing activities	(120,821)	(285,793)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3,894	(2,086)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	1,021,798	1,078,205
Net (decrease) increase in cash, cash equivalents and restricted cash	(145,550)	(399,589)
Cash, cash equivalents and restricted cash, end of period	876,248	678,616
Reportable Legal Entities | Financial Services Entities
Cash flows from operating activities:
Net income	45,278	63,388
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization	2,232	2,152
Amortization of deferred loan origination costs	21,858	22,995
Amortization of financing origination fees	2,834	3,527
Provision for long-term employee benefits	0	0
Employee benefit plan contributions and payments	0	0
Stock compensation expense	1,134	670
Net change in wholesale finance receivables related to sales	0	0
Provision for credit losses	52,364	28,822
Deferred income taxes	1,717	665
Other, net	(3,418)	67
Changes in current assets and liabilities:
Accounts receivable, net	0	0
Finance receivables – accrued interest and other	2,252	3,115
Inventories, net	0	0
Accounts payable and accrued liabilities	379,094	289,876
Other current assets	13,131	14,467
Total adjustments	473,198	366,356
Net cash provided by operating activities	518,476	429,744
Cash flows from investing activities:
Capital expenditures	(220)	(850)
Origination of finance receivables	(2,100,019)	(2,023,861)
Collections on finance receivables	1,586,477	1,724,863
Other investing activities	0	0
Net cash used by investing activities	(513,762)	(299,848)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	693,276	495,785
Repayments of medium-term notes	(350,000)	(550,000)
Repayments of securitization debt	(310,640)	(271,499)
Borrowings of asset-backed commercial paper		62,455
Repayments of asset-backed commercial paper	(62,634)	(56,634)
Net (decrease) increase in unsecured commercial paper	(270,119)	64,521
Net increase in deposits	51,822	57,660
Dividends paid	0	0
Repurchase of common stock	0	0
Other financing activities	0
Net cash provided (used) by financing activities	299,411	(197,712)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(74)	343
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	557,379	947,014
Net (decrease) increase in cash, cash equivalents and restricted cash	304,051	(67,473)
Cash, cash equivalents and restricted cash, end of period	861,430	879,541
Consolidating Adjustments
Cash flows from operating activities:
Net income	166	153
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization	0	0
Amortization of deferred loan origination costs	0	0
Amortization of financing origination fees	0	0
Provision for long-term employee benefits	0	0
Employee benefit plan contributions and payments	0	0
Stock compensation expense	0	0
Net change in wholesale finance receivables related to sales	(487,314)	(205,727)
Provision for credit losses	0	0
Deferred income taxes	(330)	(534)
Other, net	(166)	(153)
Changes in current assets and liabilities:
Accounts receivable, net	348,228	244,336
Finance receivables – accrued interest and other	0	0
Inventories, net	0	0
Accounts payable and accrued liabilities	(349,917)	(269,453)
Other current assets	2,084	25,651
Total adjustments	(487,415)	(205,880)
Net cash provided by operating activities	(487,249)	(205,727)
Cash flows from investing activities:
Capital expenditures	0	0
Origination of finance receivables	1,182,874	965,400
Collections on finance receivables	(695,625)	(759,673)
Other investing activities	0	0
Net cash used by investing activities	487,249	205,727
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	0	0
Repayments of medium-term notes	0	0
Proceeds from securitization debt	0
Repayments of securitization debt	0	0
Borrowings of asset-backed commercial paper		0
Repayments of asset-backed commercial paper	0	0
Net (decrease) increase in unsecured commercial paper	0	0
Net increase in deposits	0	0
Dividends paid	0	0
Repurchase of common stock	0	0
Other financing activities	0
Net cash provided (used) by financing activities	0	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	0
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period	0	0
Net (decrease) increase in cash, cash equivalents and restricted cash	0	0
Cash, cash equivalents and restricted cash, end of period	$ 0	$ 0